191 related articles for article (PubMed ID: 24356809)
1. Turpentine oil induced inflammation decreases absorption and increases distribution of phenacetin without altering its elimination process in rats.
Prasad VG; Vivek Ch; Anand Kumar P; Ravi Kumar P; Rao GS
Eur J Drug Metab Pharmacokinet; 2015 Mar; 40(1):23-8. PubMed ID: 24356809
[TBL] [Abstract][Full Text] [Related]
2. Phenacetin pharmacokinetics in CYP1A2-deficient beagle dogs.
Whiterock VJ; Morgan DG; Lentz KA; Orcutt TL; Sinz MW
Drug Metab Dispos; 2012 Feb; 40(2):228-31. PubMed ID: 22074769
[TBL] [Abstract][Full Text] [Related]
3. In vivo pharmacokinetic interaction by ethanolic extract of Gymnema sylvestre with CYP2C9 (Tolbutamide), CYP3A4 (Amlodipine) and CYP1A2 (Phenacetin) in rats.
Vaghela M; Sahu N; Kharkar P; Pandita N
Chem Biol Interact; 2017 Dec; 278():141-151. PubMed ID: 29042257
[TBL] [Abstract][Full Text] [Related]
4. The influence of ethnic factors and gender on CYP1A2-mediated drug disposition: a comparative study in Caucasian and Chinese subjects using phenacetin as a marker substrate.
Bartoli A; Xiaodong S; Gatti G; Cipolla G; Marchiselli R; Perucca E
Ther Drug Monit; 1996 Oct; 18(5):586-91. PubMed ID: 8885124
[TBL] [Abstract][Full Text] [Related]
5. Effects of Ziziphus jujuba fruit extracts on cytochrome P450 (CYP1A2) activity in rats.
Jing XY; Peng YR; Wang XM; Duan JA
Chin J Nat Med; 2015 Aug; 13(8):588-94. PubMed ID: 26253491
[TBL] [Abstract][Full Text] [Related]
6. The impaired disposition of probe drugs is due to both liver and kidney dysfunctions in CCl(4)-model rats.
Zhang Y; Jia Y; Yang M; Yang P; Tian Y; Xiao A; Wen A
Environ Toxicol Pharmacol; 2012 May; 33(3):453-8. PubMed ID: 22407168
[TBL] [Abstract][Full Text] [Related]
7. Possible enhancement of the first-pass metabolism of phenacetin by ingestion of grape juice in Chinese subjects.
Xiao Dong S; Zhi Ping Z; Zhong Xiao W; Chong Shu C; Fattore C; Gatti G; D'urso S; Perucca E
Br J Clin Pharmacol; 1999 Oct; 48(4):638-40. PubMed ID: 10583039
[TBL] [Abstract][Full Text] [Related]
8. Omeprazole does not enhance the metabolism of phenacetin, a marker of CYP1A2 activity, in healthy volunteers.
Xiaodong S; Gatti G; Bartoli A; Cipolla G; Crema F; Perucca E
Ther Drug Monit; 1994 Jun; 16(3):248-50. PubMed ID: 8085279
[TBL] [Abstract][Full Text] [Related]
9. THE EFFECT OF TOTAL AND PARTIAL NEPHRECTOMY ON THE PHARMACOKINETICS OF INTRAVENOUS PARACETAMOL IN HUMANS.
Karbownik A; Polom W; Porazka J; Szalek E; Grabowski T; Wolc A; Matuszewski Marcin ; Grzesowiak E
Acta Pol Pharm; 2017 May; 74(3):929-935. PubMed ID: 29513963
[TBL] [Abstract][Full Text] [Related]
10. The pharmacokinetic profile of intravenous paracetamol in adult patients undergoing major abdominal surgery.
Owens KH; Medlicott NJ; Zacharias M; Curran N; Chary S; Thompson-Fawcett M; Reith DM
Ther Drug Monit; 2012 Dec; 34(6):713-21. PubMed ID: 23149443
[TBL] [Abstract][Full Text] [Related]
11. Effects of major tanshinones isolated from Danshen (Salvia miltiorrhiza) on rat CYP1A2 expression and metabolism of model CYP1A2 probe substrates.
Wang X; Lee WY; Or PM; Yeung JH
Phytomedicine; 2009 Aug; 16(8):712-25. PubMed ID: 19403289
[TBL] [Abstract][Full Text] [Related]
12. Mechanistic and Quantitative Understanding of Pharmacokinetics in Zebrafish Larvae through Nanoscale Blood Sampling and Metabolite Modeling of Paracetamol.
Van Wijk RC; Krekels EHJ; Kantae V; Ordas A; Kreling T; Harms AC; Hankemeier T; Spaink HP; van der Graaf PH
J Pharmacol Exp Ther; 2019 Oct; 371(1):15-24. PubMed ID: 31371482
[TBL] [Abstract][Full Text] [Related]
13. In-vitro and in-vivo evaluations of cytochrome P450 1A2 interactions with nuciferine.
Hu L; Xu W; Zhang X; Su J; Liu X; Li H; Zhang W
J Pharm Pharmacol; 2010 May; 62(5):658-62. PubMed ID: 20609070
[TBL] [Abstract][Full Text] [Related]
14. Enzyme-inducing effects of berberine on cytochrome P450 1A2 in vitro and in vivo.
Jiang B; Meng L; Zhang F; Jin X; Zhang G
Life Sci; 2017 Nov; 189():1-7. PubMed ID: 28893642
[TBL] [Abstract][Full Text] [Related]
15. On the pharmacokinetics of phenacetin in man.
Raaflaub J; Dubach UC
Eur J Clin Pharmacol; 1975 Apr; 8(3-4):261-5. PubMed ID: 1233222
[TBL] [Abstract][Full Text] [Related]
16. Alteration of phenacetin pharmacokinetics after experimental spinal cord injury.
Cruz L; Castañeda-Hernández G; Flores-Murrieta FJ; García-López P; Guízar-Sahagún G
Proc West Pharmacol Soc; 2002; 45():4-5. PubMed ID: 12434508
[No Abstract] [Full Text] [Related]
17. Influence of the Time of Intravenous Administration of Paracetamol on its Pharmacokinetics and Ocular Disposition in Rabbits.
Karbownik A; Bienert A; Płotek W; Grabowski T; Cerbin-Koczorowska M; Wolc A; Grześkowiak E
Eur J Drug Metab Pharmacokinet; 2017 Jun; 42(3):489-498. PubMed ID: 27485347
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics and ocular disposition of paracetamol and paracetamol glucuronide in rabbits with diabetes mellitus induced by alloxan.
Bienert A; Kamińska A; Olszewski J; Gracz J; Grabowski T; Wolc A; Grześkowiak E
Pharmacol Rep; 2012; 64(2):421-7. PubMed ID: 22661194
[TBL] [Abstract][Full Text] [Related]
19. Saliva vs. plasma bioequivalence of paracetamol in humans: validation of class I drugs of the salivary excretion classification system.
Idkaidek N; Arafat T
Drug Res (Stuttg); 2014 Oct; 64(10):559-62. PubMed ID: 24452519
[TBL] [Abstract][Full Text] [Related]
20. Bioequivalence study comparing a new paracetamol solution for injection and propacetamol after single intravenous infusion in healthy subjects.
Flouvat B; Leneveu A; Fitoussi S; Delhotal-Landes B; Gendron A
Int J Clin Pharmacol Ther; 2004 Jan; 42(1):50-7. PubMed ID: 14756388
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
